| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101691401A Calcium carbonate binding protein, code gene thereof and application thereof |
| 04/07/2010 | CN101691397A Nisin mutant protein, code gene thereof and application thereof |
| 04/07/2010 | CN101278865B Partition type tissue engineering spinal cord |
| 04/07/2010 | CN101044837B Method for breeding hybrid of rape and cruciferae vegetables by using wild leaf mustard sterile cytoplasm |
| 04/07/2010 | CN101016540B Method of preparing HOXB4 recombination protein with histidine mark at C-end and use of the same |
| 04/06/2010 | US7692069 Soybean cultivar SG3865N |
| 04/06/2010 | US7692061 Maize cellulose synthase encoding sequences and uses thereof |
| 04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691969 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 04/06/2010 | US7691824 Double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of one of the genes of the JC virus and the use of the dsRNA to treat pathological processes mediated by JC virus infection, such as PML; sense, antisense |
| 04/06/2010 | US7691632 Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression |
| 04/06/2010 | US7691630 composition for foliar application to plants comprising a plant systemic inducer and a reactive oxygen species wherein the amount of reactive oxygen species is sufficient to increase the level of a natural plant product; for improving plant quality and yield in the presence of pathogens |
| 04/06/2010 | US7691629 culturing human neural stem cells (NSC); facilitating the ability of the transplanted NSCs to secrete trophic molecules which can be delivered to degenerating motor neurons under conditions of optimal biovailability |
| 04/06/2010 | US7691610 Vectors and host cells for Zven biodrug production; agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis |
| 04/06/2010 | US7691606 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 04/06/2010 | US7691605 Selection of cells expressing heteromeric polypeptides |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691589 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens |
| 04/06/2010 | US7691577 having controlling effects on growth and differentiation of undifferentiated cells; can affect stem cells to trigger the growth arrest signal; inhibits a SELF promoter activity |
| 04/06/2010 | US7691575 identifying a composition that increase immune response; Asteraceae plant extract; identifying stable compositions for increasing endogenous cytokine levels |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691415 Method for preventing, or reducing the severity of, graft-versus-host disease using pluri-differentiated mesenchymal progenitor cells |
| 04/06/2010 | US7691414 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 04/06/2010 | US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis |
| 04/06/2010 | US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics |
| 04/06/2010 | US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 04/06/2010 | US7691384 using a human Fc epsilon receptor (Fc68 R) to detect epsilon immunoglobulin (IgE); detecting a plant allergy in a canid, felid or equid |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes |
| 04/06/2010 | US7691373 Antibody that binds to mammalian Dendritic Cell Membrane Protein (DCMP) genes; immunostimulants |
| 04/06/2010 | US7691369 usig apparatus comprising polyethylene glycol and polylactide hydrophilic segments for propagating parenchymal cells; transplantation, organo-regeneration engineering, hybrid-type prosthesis |
| 04/06/2010 | CA2445035C Mutants of green fluorescent protein |
| 04/06/2010 | CA2410931C Mammalian gamete and embryo culture media supplement and method of using same |
| 04/06/2010 | CA2406807C Methods and compositions for the prevention and treatment of anemia |
| 04/06/2010 | CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 04/06/2010 | CA2339182C Improvement of cardiac function by mesenchymal stem cell transplantation |
| 04/06/2010 | CA2303477C Chimaeric adenoviruses |
| 04/06/2010 | CA2271952C Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 04/06/2010 | CA2252466C Hepatitis b monoclonal antibodies |
| 04/06/2010 | CA2188919C Monoclonal antibodies which promote central nervous system remyelination |
| 04/01/2010 | WO2010037130A2 Compositions and methods of generating reprogrammed adipocyte cells and methods of use therefore |
| 04/01/2010 | WO2010037092A1 Self-regulating device for modulating inflammation |
| 04/01/2010 | WO2010037049A2 Polymeric films to enhance cell growth |
| 04/01/2010 | WO2010037041A2 Frizzled-binding agents and uses thereof |
| 04/01/2010 | WO2010037016A1 Soybean transgenic event mon87705 and methods for detection thereof |
| 04/01/2010 | WO2010037001A2 Selective oxidation of 5-methylcytosine by tet-family proteins |
| 04/01/2010 | WO2010036964A2 Modified animal erythropoietin polypeptides and their uses |
| 04/01/2010 | WO2010036923A1 Induced pluripotent stem cells and methods of use |
| 04/01/2010 | WO2010036767A1 High titer antibody production |
| 04/01/2010 | WO2010036373A2 Hematopoietic stem cell growth factor |
| 04/01/2010 | WO2010036293A1 Malaria vaccine |
| 04/01/2010 | WO2010036257A1 Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010035756A1 Immunoglobulin-binding protein |
| 04/01/2010 | WO2010035465A1 Anti-tuna vasa antibody |
| 04/01/2010 | WO2010035136A2 Expansion of embryonic stem cells |
| 04/01/2010 | WO2010034469A1 Device for renal cell expansion |
| 04/01/2010 | WO2010034428A2 Method for reducing deposits during the cultivation of organisms |
| 04/01/2010 | WO2010034103A1 Method for polyclonal immunoglobulin g production by human b cells |
| 04/01/2010 | WO2010015831A3 Process for cultivating cells |
| 04/01/2010 | WO2010015619A3 Cell-based method for rebuilding bone |
| 04/01/2010 | WO2010013012A3 Hypothermia inducing polypeptides and uses thereof |
| 04/01/2010 | WO2010008157A3 Method for differentiating stem cells from ectodermal cells |
| 04/01/2010 | WO2010000127A9 Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale |
| 04/01/2010 | WO2010000125A9 The key technologies of isolation, purification, freeze-drying, anabiosis of fetal liver hemopoietic stem cell and the preparation methods |
| 04/01/2010 | WO2009094751A8 An anti-cancer cytotoxic monoclonal antibody |
| 04/01/2010 | US20100083409 Expression vector comprising genetic insulator elements for enhancing transcription of insect resistance genes |
| 04/01/2010 | US20100083408 Gene Expression Modulating Element |
| 04/01/2010 | US20100083407 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 04/01/2010 | US20100083405 Method For Controlling Seed Germination In Non-Dormant Seeds And Use Thereof |
| 04/01/2010 | US20100083403 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 04/01/2010 | US20100083395 Stress-related polynucleotides and polypeptides in plants |
| 04/01/2010 | US20100083393 Method of constructing clone mammal |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 04/01/2010 | US20100081711 Cytotoxic agents |
| 04/01/2010 | US20100081709 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses |
| 04/01/2010 | US20100081704 Modulator compounds of the drug resistance in epithelial tumour cells |
| 04/01/2010 | US20100081703 Tri-demethylation-capable protein complex, method of its preparation and its use |
| 04/01/2010 | US20100081699 Yeast platform construction and screening methods |
| 04/01/2010 | US20100081681 Methods and compositions for preventing or treating age-related diseases |
| 04/01/2010 | US20100081201 Olig1 mini-promoters |
| 04/01/2010 | US20100081200 Formulations and methods for culturing stem cells |
| 04/01/2010 | US20100081199 Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors |
| 04/01/2010 | US20100081198 Method for the repair of mutated rna from genetically defective dna and for the specific destruction of tumor cells by rna trans-splicing, and a method for the detection of naturally trans-spliced cellular rna |
| 04/01/2010 | US20100081197 In vivo modulation of neuronal transport |
| 04/01/2010 | US20100081196 Method for Separating a Volume of Whole Blood Into At Least Three Components |
| 04/01/2010 | US20100081121 Media and method for cell separation |
| 04/01/2010 | US20100080836 Method and means for culturing osteoblastic cells |
| 04/01/2010 | US20100080828 Immunogenic sequences |
| 04/01/2010 | US20100080819 Modulators of p-selectin glycoprotein ligand 1 |
| 04/01/2010 | US20100080816 Tolerogenic populations of dendritic cells |
| 04/01/2010 | US20100080815 MN Gene and Protein |
| 04/01/2010 | US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 04/01/2010 | US20100080812 Antibodies against human IL17 and uses thereof |
| 04/01/2010 | US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 04/01/2010 | US20100080806 Anti-human trail receptor dr5 monoclonal antibody (ad5-10), method thereof and use of the same |
| 04/01/2010 | US20100080801 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |